|
NZ210669A
(en)
|
1983-12-27 |
1988-05-30 |
Syntex Inc |
Benzoxazin-4-one derivatives and pharmaceutical compositions
|
|
JPH05194406A
(ja)
|
1991-11-12 |
1993-08-03 |
Yoshitomi Pharmaceut Ind Ltd |
新規アミド化合物
|
|
SE9600769D0
(sv)
|
1996-02-28 |
1996-02-28 |
Astra Ab |
Compounds useful as analgesic
|
|
WO1998017636A1
(en)
|
1996-10-22 |
1998-04-30 |
Ortho Pharmaceutical Corporation |
Phenylalaninol derivatives for the treatment of central nervous system disorders
|
|
US6900228B1
(en)
|
1998-03-10 |
2005-05-31 |
Research Triangle Institute |
Opiate compounds, methods of making and methods of use
|
|
DE10252666A1
(de)
|
2002-11-11 |
2004-08-05 |
Grünenthal GmbH |
N-Piperidyl-cyclohexan-Derivate
|
|
AU2003264676A1
(en)
|
2003-06-27 |
2005-02-14 |
Applications Technologiques Avancees, A.T.A. |
Novel confinement or isolation box
|
|
EP1698375B1
(en)
|
2003-12-25 |
2014-04-02 |
Ono Pharmaceutical Co., Ltd. |
Azetidine ring compounds and drugs comprising the same
|
|
EP1598341A1
(en)
*
|
2004-05-21 |
2005-11-23 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
DPP-IV inhibitors
|
|
EP1604662A1
(en)
|
2004-06-08 |
2005-12-14 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus
|
|
WO2007115231A2
(en)
|
2006-03-30 |
2007-10-11 |
Chemocentryx, Inc. |
Cxcr4 modulators
|
|
KR20080071476A
(ko)
|
2007-01-30 |
2008-08-04 |
주식회사 엘지생명과학 |
신규한 디펩티딜 펩티데이즈 ｉｖ(ｄｐｐ-ｉｖ) 저해제
|
|
GB0813740D0
(en)
|
2008-07-28 |
2008-09-03 |
Angeletti P Ist Richerche Biologica |
Therapeutic compounds
|
|
CN101823987B
(zh)
|
2009-03-06 |
2014-06-04 |
中国科学院上海药物研究所 |
一类新的dpp-ⅳ抑制剂及其制备方法和用途
|
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2539706B1
(en)
|
2010-02-24 |
2015-03-04 |
Research Triangle Institute |
Arylpiperazine opioid receptor antagonists
|
|
WO2013006734A1
(en)
|
2011-07-05 |
2013-01-10 |
St. Jude Children's Research Hospital |
Substituted 4-phenoxyphenol analogs as modulators of proliferating cell nuclear antigen activity
|
|
WO2013033310A1
(en)
|
2011-08-31 |
2013-03-07 |
Theodore Mark Kamenecka |
Modulators of rev-erb
|
|
EP2776400A1
(en)
|
2011-11-09 |
2014-09-17 |
Grünenthal GmbH |
Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with a co-containing group as vanilloid receptor ligands
|
|
WO2017007695A1
(en)
|
2015-07-09 |
2017-01-12 |
The Regents Of The University Of California |
Mu opioid receptor modulators
|
|
WO2017035366A1
(en)
|
2015-08-26 |
2017-03-02 |
Incyte Corporation |
Pyrrolopyrimidine derivatives as tam inhibitors
|
|
EP3565543A4
(en)
|
2017-01-06 |
2020-10-14 |
The Regents of The University of California |
MU TYPE OPIOID RECEIVER MODULATORS
|
|
US10780078B2
(en)
|
2017-08-17 |
2020-09-22 |
The Regents Of The University Of California |
Mu opioid receptor modulators
|
|
JP7402857B2
(ja)
|
2018-04-04 |
2023-12-21 |
エピオダイン，インク． |
オピオイド受容体モジュレーター、およびそれに関連する生成物ならびに方法
|
|
TW202304869A
(zh)
|
2021-04-05 |
2023-02-01 |
美商艾碧奧戴股份有限公司 |
類鴉片受體調節劑
|